Segment reporting (Details) |
3 Months Ended | 6 Months Ended | |||
---|---|---|---|---|---|
Jun. 30, 2025
CHF (SFr)
|
Jun. 30, 2024
CHF (SFr)
|
Jun. 30, 2025
CHF (SFr)
segment
|
Jun. 30, 2024
CHF (SFr)
|
Dec. 31, 2024
CHF (SFr)
|
|
Segments | |||||
Number of segments | segment | 1 | ||||
Collaborative research funding | SFr 115,277 | SFr 348,757 | |||
Fair value of services received at zero cost from Neurosterix Group | SFr 34,505 | SFr 105,560 | |||
Other service income | 1,870 | 1,870 | 1,430 | ||
Revenue and other operating income | 36,375 | 115,277 | 107,430 | 350,187 | |
Long-lived assets | 5,848,435 | 5,848,435 | SFr 7,136,940 | ||
Operating costs | 769,273 | 1,014,593 | 1,446,590 | 2,037,595 | |
Capital expenditure | 0 | 0 | 0 | 0 | |
Switzerland | |||||
Segments | |||||
Long-lived assets | 5,848,099 | 5,848,099 | 7,136,602 | ||
Operating costs | 765,310 | 1,010,390 | 1,439,158 | 2,031,464 | |
United States of America | |||||
Segments | |||||
Operating costs | 2,840 | 2,371 | 5,155 | 4,017 | |
France | |||||
Segments | |||||
Long-lived assets | 336 | 336 | SFr 338 | ||
Operating costs | 1,123 | 1,832 | 2,277 | 2,114 | |
Indivior PLC | |||||
Segments | |||||
Revenue and other operating income | SFr 115,277 | 348,757 | |||
Neurosterix Group | |||||
Segments | |||||
Revenue and other operating income | 34,505 | 105,560 | |||
Other counterparties | |||||
Segments | |||||
Revenue and other operating income | SFr 1,870 | SFr 1,870 | SFr 1,430 |